Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.71%
1,092.80
-7.77
-0.71%
—1,100.571,098.941,103.801,084.24——
SIXC
Communications
SIXC
Communications
SIXC
-0.07%
604.74
-0.41
-0.07%
—605.15605.15606.69602.76——
SIXE
Energy
SIXE
Energy
SIXE
+1.64%
1,214.80
+19.61
+1.64%
—1,195.191,204.711,221.691,204.71——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,724.57
-15.34
-0.88%
—1,739.911,734.501,734.501,710.67——
SIXM
Financials
SIXM
Financials
SIXM
+0.14%
639.43
+0.87
+0.14%
—638.56640.21645.32638.69——
SIXR
Staples
SIXR
Staples
SIXR
+0.91%
839.15
+7.58
+0.91%
—831.57840.48844.16834.54——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.06%
215.62
+2.26
+1.06%
—213.36213.36215.79212.77——
SIXT
Technology
SIXT
Technology
SIXT
-1.69%
3,179.52
-54.66
-1.69%
—3,234.183,171.863,195.363,145.46——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.13%
936.91
+1.26
+0.13%
—935.65937.31941.44933.16——
SIXV
Health care
SIXV
Health care
SIXV
+0.24%
1,452.77
+3.51
+0.24%
—1,449.261,454.771,462.651,447.95——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,365.18
-17.27
-0.72%
—2,382.452,371.192,380.452,362.86——
PHCUF:OTCMKTS
Photocure ASA
$7.07
0.00%
(0.00) 1D
Mar 12, 9:45:47 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PHCUF...
Avg. vol.
3.00
Volume
0.00
52-wk high
$7.07
52-wk low
$4.95
Beta
-0.27
Shares outstanding
27.12M
No. of employees
102
News stories
From sources across the web
Profile
Photocure ASA is a Norwegian specialty pharma company that develops and sells pharmaceuticals and medical devices based on proprietary photodynamic technology. Photocure's strategy in cancer is to continue the commercialization of Hexvix for bladder cancer diagnostics, and continue the development of the cancer portfolio and out-license prior to phase III studies. This strategy is based on a strong platform of intellectual property in photodynamic therapy. Wikipedia
About Photocure ASA
CEO-
Employees102
Founded1993
Headquarters-
SectorPharmaceutical industry
Websitephotocure.com
Previous reportsAll values in NOK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in NOK
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
125.34M
135.62M
134.96M
136.67M
Cost of goods sold
9.14M
10.04M
11.89M
10.93M
Cost of revenue
9.14M
10.04M
11.89M
10.93M
Research and development expenses
1.17M
506.00K
-862.00K
-414.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
93.61M
89.01M
93.60M
103.93M
Operating expense
121.77M
118.12M
120.69M
131.26M
Total operating expenses
130.91M
128.16M
132.57M
142.18M
Operating income
-5.58M
7.46M
2.39M
-5.52M
Other non operating income
1.00K
-
-
2.00K
EBT including unusual items
-9.39M
2.51M
-398.00K
-9.42M
EBT excluding unusual items
-9.39M
2.51M
-398.00K
-9.42M
Income tax expense
-6.98M
-2.35M
-4.38M
-1.47M
Effective tax rate
74.31%
-93.55%
1,100.75%
15.56%
Other operating expenses
26.99M
28.60M
27.95M
27.74M
Net income
-2.41M
4.86M
3.98M
-7.95M
Net profit margin
-1.92%
3.59%
2.95%
-5.82%
Earnings per share
-0.09
-
0.15
-0.30
Interest and investment income
5.20M
4.97M
4.22M
3.25M
Interest expense
-9.01M
-9.91M
-7.50M
-7.16M
Net interest expenses
-3.81M
-4.94M
-3.28M
-3.91M
Depreciation and amortization charges
-
-
-
-
EBITDA
318.00K
14.76M
9.72M
1.92M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer